• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Neurology

ECTRIMS 2019 DAILY REPORT – SATURDAY EDITION

September 14, 2019  

Ofatumumab – new data
Biotin – disappointing results
Natalizumab – 10-year data
Dimethyl fumarate – 10-year results
Declining effect of treatment
Stopping treatment: 2 studies
BTK inhibition
Clinical Tip of the day Read More

TOPICS: MS

ECTRIMS 2019 DAILY REPORT – FRIDAY EDITION

September 13, 2019  

Siponimod in SPMS
Alemtuzumab – 9-year results
Ocrelizumab in PPMS – extension data
Starting and switching DMTs
RIS – Predictors of CIS/MS
Do real-world people enter real-world studies?
Clinical Tip of the day Read More

TOPICS: MS

ECTRIMS Poster Picks – Friday, September 13

September 13, 2019  

Friday, September 13, 2019 – Today’s poster session runs from 12:15-2:15 pm
Here are Steven’s Top poster topics at ECTRIMS for Friday, September 13, 2019. Read More

ECTRIMS 2019 DAILY REPORT – THURSDAY EDITION

September 12, 2019  

Phase III trials in NMOSD
Cladribine and time to SPMS
Hypogammaglobulinemia
Cannabis and cognition
Concussion and MS
Clinical Tip of the day Read More

TOPICS: MS

ECTRIMS Poster Picks – Thursday, September 12

September 12, 2019  

Thursday, September 12, 2019 – Today’s poster session runs from 5:15-7:15 pm
Here are Steven’s Top poster topics at ECTRIMS for Thursday, September 12. Read More

Previous
45
46
47
48
49
Next

Browse by Topic

  • MS (442)
  • EAN 2026 (2)
  • CLINICAL CASES (21)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • EPILEPSY (38)
  • AES 2025 (1)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • Anti-CD20 therapy in MS: comparing efficacy and safety posted on July 21, 2026
  • Management of refractory epilepsy: highlights from ILAE 2025 posted on October 29, 2025
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions